LaChapelle Robin

Filings at 1 company/Chief operating officer · ArriVent BioPharma, Inc.

5 of 10 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 10. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 10 visible filings, newest first.

ArriVent BioPharma, Inc. Chief operating officer
17,648 sharesOption exercise
TradedOct 30, 2026FiledNov 2, 2026
ArriVent BioPharma, Inc. Chief operating officer
16,265 sharesOption exercise
TradedOct 30, 2026FiledNov 2, 2026
ArriVent BioPharma, Inc. Chief operating officer
1,820 sharesOption exercise
TradedOct 30, 2026FiledNov 2, 2026
ArriVent BioPharma, Inc. Chief operating officer
4,550 sharesOption exercise
TradedOct 30, 2026FiledNov 2, 2026
ArriVent BioPharma, Inc. Chief operating officer
410 sharesOption exercise
TradedOct 30, 2026FiledNov 2, 2026